| Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain (NCT00671710) | Advocate Hospital System | 2008-04-01 |
| Cervical Spinal Cord Stimulation for the Prevention of Cerebral Vasospasm (NCT00766844) | Konstantin V. Slavin | 2008-04-01 |
| The Acute Effects of Capsiate During Exercise (NCT00692601) | Hamilton Health Sciences Corporation | 2008-04-01 |
| EMD 640 744 in Montanide ISA 51 VG Administered in Subjects With Advanced Solid Tumors (NCT01012102) | Merck KGaA, Darmstadt, Germany | 2008-04-01 |
| Chemoradiation Treatment for Head and Neck Cancer (NCT00704639) | Trans Tasman Radiation Oncology Group | 2008-04-01 |
| TMC114-TiDP29-C169: Bioavailability and Pharmacokinetics Trial Comparing Darunavir Pediatric Suspension Formulation to Current Darunavir Tablet (NCT00752310) | Tibotec Pharmaceuticals, Ireland | 2008-04-01 |
| Analgesic Efficacy of Local Anesthetic Transversus Abdominis Plane (TAP) Blocks in Abdominal Surgery (NCT00682136) | Hunter Colorectal Research | 2008-04-01 |
| CS-8958 Single Inhaled Dose in Elderly (NCT00657111) | Biota Scientific Management Pty Ltd | 2008-04-01 |
| BION Treatment of Knee Osteoarthritis (NCT00689286) | University of Southern California | 2008-04-01 |
| Pharmacokinetics, Safety & Tolerability of ZD4054 (Zibotentan) in Subjects With Normal, Mild, Moderate and Severe Hepatic Impairment (NCT00672581) | AstraZeneca | 2008-04-01 |
| Velcaflagida in Relapsed or Refractary Acute Myeloid Leukemia (NCT00651781) | PETHEMA Foundation | 2008-04-01 |
| A Study of the Safety of PAZ-417 in Healthy Elderly Adults (NCT00663065) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-04-01 |
| Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications (NCT00877591) | University of California, San Francisco | 2008-04-01 |
| Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg/38 mg Caplets Under Fasting Condition (NCT01053208) | Dr. Reddy's Laboratories Limited | 2008-04-01 |
| Study Evaluating the Effects of PSI-697 on Platelets in Subjects Who Smoke (NCT03860506) | Pfizer | 2008-04-01 |
| Drug Interaction Study (NCT00646776) | Bristol-Myers Squibb | 2008-04-01 |
| Safety, Tolerability, and Pharmacokinetics of BI 201335 NA in Healthy Male Subjects (NCT02182297) | Boehringer Ingelheim | 2008-04-01 |
| Coenzyme Q10 in Adult-Onset Ataxia (NCT00957216) | The University of Texas Medical Branch, Galveston | 2008-04-01 |
| Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma (NCT00662506) | National Cancer Institute (NCI) | 2008-04-01 |
| A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers (NCT00743769) | RegeneRx Biopharmaceuticals, Inc. | 2008-04-01 |
| AZD 2066 Single Dose Formulation and Food Effect Study in Healthy Volunteers (NCT00690404) | AstraZeneca | 2008-04-01 |
| Prenatal Steroids for Treatment of Congenital Cystic Adenomatoid Malformations (CCAM) (NCT00670956) | University of California, San Francisco | 2008-04-01 |
| Study to Investigate AKT Inhibitor GSK690693 in Subjects With Relapsed or Refractory Hematologic Malignancies (NCT00666081) | GlaxoSmithKline | 2008-04-01 |
| Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes (NCT00624936) | Ohio State University Comprehensive Cancer Center | 2008-04-01 |
| Study of Polyester Implants for the Treatment of External Nasal Valve Collapse (NVC) (NCT00729781) | Medtronic Xomed, Inc. | 2008-04-01 |
| A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC) (NCT00666692) | Abbott | 2008-04-01 |
| Study to Investigate the Effect of Ketoconazole Mediated CYP3A4 Inhibition on Pharmacokinetics of Tamsulosin in Healthy Male Volunteers (NCT02264171) | Boehringer Ingelheim | 2008-04-01 |
| A Trial of Panobinostat and Trastuzumab for Adult Female Patients With HER2 Positive Metastatic Breast Cancer (MBC) Whose Disease Has Progressed on or After Trastuzumab (NCT00567879) | Novartis Pharmaceuticals | 2008-04-01 |
| Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia (NCT01556763) | FORUM Pharmaceuticals Inc | 2008-04-01 |
| First-line Therapy of Stage IV Colorectal Cancer (NCT00784446) | University of Cologne | 2008-04-01 |
| Safety Study of Oral MGCD265 Administered With Interruption to Subjects With Advanced Malignancies (NCT00679133) | Mirati Therapeutics Inc. | 2008-04-01 |
| Safety Study of TAK-700 in Subjects With Prostate Cancer. (NCT00569153) | Millennium Pharmaceuticals, Inc. | 2008-04-01 |
| Pharmacokinetic Properties of Two Dosages Nevirapine Extended Release (XR) Formulations Compared to VIRAMUNE® Tablet as Well as to Nevirapine XR Tablet in Healthy Male Volunteers (NCT02184312) | Boehringer Ingelheim | 2008-04-01 |
| Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes (NCT01868568) | Novo Nordisk A/S | 2008-04-01 |
| Transtympanic Ringer's Lactate for the Prevention of Cisplatin Ototoxicity (NCT01108601) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2008-04-01 |
| A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers. (NCT00661765) | Pfizer | 2008-04-01 |
| A Clinical Trial of CoFactor Formulations and Leucovorin Administered Intravenously in Healthy, Adult Subjects. (NCT00663481) | Mast Therapeutics, Inc. | 2008-04-01 |
| Experimental Medicine Study to Validate Pharmacodynamic Pain Assessments in Healthy Volunteers With an Opioid Analgesic (Remifentanil) (NCT02602002) | GlaxoSmithKline | 2008-04-01 |
| A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00112060) | Spectrum Pharmaceuticals, Inc | 2008-04-01 |
| Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma (NCT00644696) | University of Michigan Rogel Cancer Center | 2008-04-01 |
| A Controlled Study of the Safety and Efficacy of Lessertia Frutescens in HIV-infected South African Adults (NCT00549523) | University of Missouri-Columbia | 2008-04-01 |
| Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic Tumours (NCT00633269) | AstraZeneca | 2008-04-01 |
| Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma (NCT00720564) | City of Hope Medical Center | 2008-04-01 |
| Clinic-Based AMES Treatment of Stroke (NCT00847704) | Oregon Health and Science University | 2008-04-01 |
| A Study to Assess the Pharmacodynamics (PD) of Prednisoline in Healthy Male Subject (NCT03196557) | Bristol-Myers Squibb | 2008-03-31 |
| A Study of AMG 820 in Subjects With Advanced Solid Tumors (NCT01444404) | AmMax Bio, Inc. | 2008-03-31 |
| Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis (NCT00641225) | Pfizer | 2008-03-31 |
| Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients (NCT00708448) | University of Utah | 2008-03-28 |
| Treatment of Participants With Advanced and/or Refractory Solid Tumors (MK-5108-001) (NCT00543387) | Merck Sharp & Dohme LLC | 2008-03-27 |
| Repeat Dose Study in Male Healthy Volunteer Smokers (NCT00615576) | GlaxoSmithKline | 2008-03-26 |
| Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study (NCT00646152) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-03-24 |
| Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery (NCT00576654) | National Cancer Institute (NCI) | 2008-03-18 |
| Phase 1 Study of Levocetirizine (NCT02447393) | GlaxoSmithKline | 2008-03-18 |
| A Study of ARRY-520 in Patients With Advanced Myeloid Leukemia (NCT00637052) | Pfizer | 2008-03-18 |
| Dasatinib in Resectable Malignant Pleural Mesothelioma (NCT00652574) | M.D. Anderson Cancer Center | 2008-03-12 |
| A Study to Investigate the Pharmacology of a Dual Pharmacophore in Healthy Volunteers (NCT00687700) | Theravance Biopharma | 2008-03-10 |
| Food Effects of Single Oral Dose of 600mg TR-701 (NCT00671359) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2008-03-10 |
| Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies (NCT00703625) | Washington University School of Medicine | 2008-03-08 |
| SNX-5422 to Treat Solid Tumor Cancers and Lymphomas (NCT00644072) | National Cancer Institute (NCI) | 2008-03-07 |
| Study to Evaluate the Safety of FSR Peptide Versus Placebo Following Punch Biopsy (NCT04473859) | Xequel Bio, Inc. | 2008-03-06 |
| Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (NCT00576979) | City of Hope Medical Center | 2008-03-04 |
| Ph I SU011248 + Irinotecan in Treatment of Pts w MG (NCT00611728) | Duke University | 2008-03-01 |
| A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure (NCT00662610) | NicOx | 2008-03-01 |
| Safety and Feasibility of the Injectable BL-1040 Implant (NCT00557531) | BioLineRx, Ltd. | 2008-03-01 |
| Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer (NCT00573989) | Wake Forest University Health Sciences | 2008-03-01 |
| Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels (NCT00671307) | Critical Biologics Corporation | 2008-03-01 |
| Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy Subjects (NCT00689559) | AstraZeneca | 2008-03-01 |
| Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction (NCT00609089) | University of Cincinnati | 2008-03-01 |
| Axillary Reverse Mapping for Invasive Carcinoma of the Breast (NCT00645541) | M.D. Anderson Cancer Center | 2008-03-01 |
| High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain (NCT00637364) | CMED HIFU Development Corporation | 2008-03-01 |
| Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme (NCT00635557) | Myrexis Inc. | 2008-03-01 |
| An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED) (NCT00642798) | Merck Sharp & Dohme LLC | 2008-03-01 |
| Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine (NCT00655395) | Viron Therapeutics Inc | 2008-03-01 |
| Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas (NCT00647764) | Esanex Inc. | 2008-03-01 |
| Study Evaluating the Safety and Tolerability of NSA-789 (NCT00633048) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-03-01 |
| Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT00616941) | Ludwig Institute for Cancer Research | 2008-03-01 |
| Study Evaluating Oral Administrations of HKI-272 in Healthy Male Subjects (NCT00550212) | Puma Biotechnology, Inc. | 2008-03-01 |
| Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia (NCT00571558) | National Cancer Institute (NCI) | 2008-03-01 |
| A Multiple Dose Safety Study of PEG-IFN in Healthy Volunteers (NCT02125578) | Biogen | 2008-03-01 |
| Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia (NCT00607451) | Neurim Pharmaceuticals Ltd. | 2008-03-01 |
| Multiple Ascending Dose Study of BMS-777607 in Subjects With Advanced or Metastatic Solid Tumors (NCT00605618) | Bristol-Myers Squibb | 2008-03-01 |
| Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D) (NCT00494195) | Nationwide Children's Hospital | 2008-03-01 |
| A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases (NCT00649207) | AbbVie (prior sponsor, Abbott) | 2008-03-01 |
| Pharmacokinetic Study: Effect of 25(OH)D and Vitamin D3 on Serum 25(OH)D (NCT00718276) | University of Zurich | 2008-03-01 |
| Study of Colon GVAX and Cyclophosphamide in Patients With Metastatic Colorectal Cancer (NCT00656123) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2008-03-01 |
| A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable (NCT00876122) | Genentech, Inc. | 2008-03-01 |
| Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241) (NCT00632073) | Merck Sharp & Dohme LLC | 2008-03-01 |
| Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Transplant (NCT00670774) | Mark Stegall | 2008-03-01 |
| Study to Investigate Safety, Tolerability and Pharmacokinetics of a Single Ascending Dose of AZD1704 (NCT00692042) | AstraZeneca | 2008-03-01 |
| Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma (NCT00604890) | BPGbio | 2008-03-01 |
| Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks (NCT00667472) | University of California, Irvine | 2008-03-01 |
| Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042) (NCT00966030) | Merck Sharp & Dohme LLC | 2008-03-01 |
| Safety Study of Oral Vinorelbine in Subjects With Non-Hematologic Malignancies (NCT00641160) | Metronome Therapeutics | 2008-03-01 |
| Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal (NCT00669825) | Alvine Pharmaceuticals Inc. | 2008-03-01 |
| A Phase I Study of CD19 Specific T Cells in CD19 Positive Malignancy (NCT01493453) | The Christie NHS Foundation Trust | 2008-03-01 |
| A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer (NCT00629057) | Bavarian Nordic | 2008-03-01 |
| Study of the Effect of Lactisole on the Intestinal Glucose Uptake (NCT00631293) | University Ghent | 2008-03-01 |
| Topical Autologous Insulin Application for the Treatment of Corneal Epithelium Defect After Ocular Surgeries (NCT01031888) | National Taiwan University Hospital | 2008-03-01 |
| Minimizing Reperfusion Injury in Patients With Acute Myocardial Infarction (NCT00846378) | University of Cincinnati | 2008-03-01 |
| Study Evaluating Safety of GSI 136 in Young and Elderly Japanese Males (NCT00719394) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-03-01 |